Northrop Grumman Commits $2.5B to B-21 Facilities, Boosts Rate 25%
Northrop Grumman plans $2.5 billion in new facility investments for its B-21 program, with CapEx of about $200 million this year and higher spending through 2027–2029 to boost production by 25% after securing Lot 4 LRIP. Space segment sales fell, weighed down by a $98 million NGI headwind and a $71 million GEM 63XL adjustment.
1. Capital Investments for B-21 Program
Northrop Grumman is investing $2.5 billion in new facilities and expects to spend approximately $200 million in CapEx this year, with the bulk of spending between 2027 and 2029. These investments aim to increase throughput on the B-21 program and support an annual production rate that could rise by 25%.
2. B-21 Production and LRIP Awards
The company secured the Lot 4 low-rate initial production award for the B-21 program after completing Lot 3, enabling a 25% increase in annual output. Early production lots experienced higher costs, but improved efficiencies have bolstered profitability on subsequent aircraft builds.
3. Space Segment Performance
First-quarter Space segment sales and operating income declined due to a $98 million headwind from the NGI program and a $71 million unfavorable earnings adjustment on the GEM 63XL program. Despite these setbacks, the segment maintains a healthy book-to-bill ratio and expects stable margins for the remainder of the year.
4. Missile Defense and International Demand
Missile defense sales, accounting for nearly 10% of total company revenue, are set to benefit from rising international demand in Europe and the Middle East. Northrop Grumman is accelerating export approvals and aggregating international orders to offset longer sales cycles outside the US.